health canada approval zepbound tirzepatide obesity canada 2024 2025 has approved the first sleep apnea drug for adults with Tirzepatide Tops Semaglutide for Weight

Aaboe K, Krarup T, Madsbad S, Holst JJ

How CenterWell supports your health journey CenterWell Pharmacy makes managing your prescriptions simple, with home delivery, medication therapy management and flexible payment options like Afterpay

These symptoms may appear gradually and should not be ignored, especially when they persist or worsen over time

The clinical playbook still needs to be written

It has a market cap of $430 billion, but Pot believes it could double as it develops more weight-loss products

The risks of injecting unlicensed, often poorly manufactured compounds are real and not adequately offset by the potential benefits, particularly when well-evidenced alternatives are available